Evidence map›Paper›PMID 41242911›Full record

ReviewAdvances in biological regulation2026

Potential endogenous lipid ligands for the nuclear receptor transcription factor Steroidogenic Factor-1.

Alexis N Campbell, Raymond D Blind

Abstract readReview
In one paragraph

Review in Advances in biological regulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alexis N CampbellDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.
Raymond D BlindDepartment of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA; Department of Medicine, Division of Diabetes, Endocrinology & Metabolism, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. Electronic address: ray.blind@vanderbilt.edu.

Funding

MOLECULAR BIOPHYSICS TRAINING PROGRAM AT VANDERBILTT32GM008320 · NIGMS · VANDERBILT UNIVERSITY · PI CHAZIN, WALTER J. · 1989 to 2023
$7.9M
Structure and function of phospholipids and inositol phosphates in the nucleus.R35GM156389 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Raymond Daniel Blind · 2025 to 2026
$1.4M
Full-length LRH-1 structural regulationR01GM138873 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BLIND, RAYMOND DANIEL · 2020 to 2023
$1.4M
Liver and kidney responses to bilirubin as a nuclear receptor hormoneR01DK141801 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Raymond Daniel Blind · 2025 to 2026
$761k
NIDDK NIH HHS R01 DK141801NIGMS NIH HHS R01 GM138873NIGMS NIH HHS R35 GM156389NIGMS NIH HHS T32 GM008320
6 · The paper itself

Abstract

Nuclear receptors are lipid-regulated transcription factors that respond to the changing metabolic and signaling requirements of animal cells and tissues. Steroidogenic Factor 1 (SF-1, NR5A1) is a nuclear receptor and master regulator of steroidogenic gene expression. SF-1 is required for development and adult function of steroidogenic tissues, hyperactivation of SF-1 associates with adrenocortical carcinoma, while hypomorphic loss-of-function polymorphisms associate with disorders of sexual development. Many of these physiological functions of SF-1 are broadly understood, however the identity of the endogenous regulatory lipid ligands for SF-1 have yet to be well established, preventing progress on therapeutic development for human diseases, such as adrenocortical carcinoma. Several signaling lipids have been put forth as potential regulatory ligands of SF-1, including sphingosine, lyso-sphingomyelin, sphingomyelin, ceramide and several phosphoinositide species including PI(4,5)P2 and PI(3,4,5)P3. Here, we review the evidence linking the ability of these potential phospholipid ligands to regulate SF-1 mediated gene expression in metazoan cells, and discuss how lipid ligands regulate SF-1 from a structural perspective.

Indexed as

Steroidogenic Factor 1AnimalsCeramidesGene Expression RegulationHumansLigandsSignal TransductionCeramidesLigandsNR5A1 protein, humanSteroidogenic Factor 1Nuclear hormone receptor ligandPhosphatidylinositol and sphingolipid receptorReceptor-mediated transcriptional activationX-ray crystallography and crystal structures

Identifiers

PMID41242911
PMCPMC12737866

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.